Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by EHRENSTEIN, M. R.
Right arrow Articles by ISENBERG, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by EHRENSTEIN, M. R.
Right arrow Articles by ISENBERG, D. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 British Society for Rheumatology


research-article

THE OCCURRENCE, NATURE AND DISTRIBUTION OF FLARES IN A COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A RHEUMATOLOGICAL VIEW

M. R. EHRENSTEIN, S. E. CONROY, J. HEATH, D. S. LATCHMAN and D. A. ISENBERG

Division of Rheumatology, Department of Medicine, University College London London

Correspondence to: Correspondence to: M. Ehrenstein, Department of Rheumatology Research, University College London Medical School, Arthur Stanley House, 40–50 Tottenham Street, London W1P 9PG.

This study examines the occurrence, nature and distribution of disease flares in systemic lupus erythematosus (SLE) according to organ involvement. One-hundred-and-fourteen patients were seen in the Lupus Clinic of the Bloomsbury Rheumatology Unit over a 3-yr period. At each visit a data sheet was completed to assess their disease activity in eight separate organs/systems according to the British Isles Lupus Assessment Group (BILAG) activity index. This information was entered into a computer and a score for each organ system was obtained. The record of each individual patient was examined to identify flares in the individual organs; 458 flares occurred in 107 patients. The majority of patients (69%) experienced more than one flare during the study period. Fifty-four per cent of patients had flares in more than one system simultaneously, but the majority (70%) of flares involved only one system. The most severe organ involvement (A score)was most commonly observed in the musculoskeletal system, whereas severe renal disease occurred only three times. These results indicate that although SLE is a multisystem disease, the flares that occur tend to be confined to one system at a time. Further, these results demonstrate that in our rheumatology practice the most common ‘A’ flare observedwas severe polyarthritis (A score in musculoskeletal).

KEY WORDS: Systemic lupus erythematosus, Flares, BILAG, Arthritis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
LupusHome page
A M Bertoli, G S Alarcon, G McGwin, M Fernandez, H M Bastian, B J Fessler, L M Vila, J D Reveille, and LUMINA Study Group
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity
Lupus, January 1, 2006; 15(1): 13 - 18.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
D. A. Isenberg, A. Rahman, E. Allen, V. Farewell, M. Akil, I. N. Bruce, D. D'Cruz, B. Griffiths, M. Khamashta, P. Maddison, et al.
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
Rheumatology, July 1, 2005; 44(7): 902 - 906.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. Gordon, N. Sutcliffe, J. Skan, T. Stoll, and D. A. Isenberg
Definition and treatment of lupus flares measured by the BILAG index
Rheumatology, November 1, 2003; 42(11): 1372 - 1379.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M. Petri, J. Buyon, and M. Kim
Classification and definition of major flares in SLE clinical trials
Lupus, October 1, 1999; 8(8): 685 - 691.
[Abstract] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.